USD10
YARW Shares
About Yarrow BioscienceYarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.

USD10
YARW Shares
About Yarrow BioscienceYarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.

Stats

TRADING WINDOW

Closed

OPENS AT

Jul 31 at 1:30 PM GMT+0

MARKET CAP

Not enough data

OPEN PRICE

$34.79

LOW (1Y)

$14.03

HIGH (1Y)

$46.95

LOW (24H)

$31.55

HIGH (24H)

$35.96

VOLUME (24H)

$18.23K

17.58%

Price history

Time
Price
Change
Today
$34.79
3.10%
1 Day
$31.55
6.85%
1 Week
$27.96
20.57%
1 Month
$27.96
20.57%
1 Year
Not enough data
Not enough data
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.